SCHEMBL1065643

SCHEMBL1065643

CCCCCOC(=O)CCCNC(=O)NC12CC3CC(CC(C3)C1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654142 0.93 EPHX2 (1.00) EPHX2
SCHEMBL1061376 0.92 EPHX2 (1.00) EPHX2
SCHEMBL1066006 0.92 EPHX2 (1.00) EPHX2
SCHEMBL12931923 0.92 EPHX2 (1.00) EPHX2
SCHEMBL14996200 0.90 EPHX2 (0.83) EPHX2
SCHEMBL1060536 0.89 EPHX2 (1.00) EPHX2
SCHEMBL19116644 0.87 EPHX2 (0.89) EPHX2
SCHEMBL19116378 0.86 EPHX2 (0.87) EPHX2
SCHEMBL12931855 0.85 EPHX2 (1.00) EPHX2
SCHEMBL12931875 0.85 EPHX2 (1.00) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 US disclosed
US-8455652-B2 Inhibitors for the soluble epoxide hydrolase THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-06-04 US disclosed
US-8455652-B2 Inhibitors for the soluble epoxide hydrolase THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-06-04 US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 US disclosed
US-20090326039-A1 INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-12-31 US disclosed
US-20090326039-A1 INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-12-31 US disclosed
EP-1814875-A2 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE The Regents of the University of California (US) 2007-08-08 EP disclosed
EP-1608319-A4 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE UNIV CALIFORNIA (US) 2007-02-28 EP disclosed
US-20060270609-A1 Inhibitors for the soluble epoxide hydrolase REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-11-30 US disclosed
WO-2006045119-A9 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE UNIV CALIFORNIA (US) 2006-05-26 WO disclosed
WO-2006045119-A2 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-04-27 WO disclosed
EP-1608319-A2 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE The Regents of the University of California (US) 2005-12-28 EP disclosed
US-20050026844-A1 Inhibitors for the soluble epoxide hydrolase REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-02-03 US disclosed
WO-2004089296-A2 IMPROVED INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326039-A1 INHIBITORS FOR THE SOLUBLE EPOXIDE HYDROLASE EPHX1, EPHX2, NCEH1 EPHX2 2/4885
US-20060270609-A1 Inhibitors for the soluble epoxide hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885
US-20050026844-A1 Inhibitors for the soluble epoxide hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.